ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36328-5mg |
|
— |
IRAK inhibitor 4 trans
|
0 | C33H35F3N6O3 | |
GC36328-2mg |
|
— |
IRAK inhibitor 4 trans
|
0 | C33H35F3N6O3 | |
GC36328-10mM (in 1mL DMSO) |
|
— |
IRAK inhibitor 4 trans
|
0 | C33H35F3N6O3 | |
GC36327-100mg |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36327-50mg |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36327-25mg |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36327-10mg |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36327-5mg |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36327-10mM (in 1mL DMSO) |
|
23146-22-7 |
IQ-1S free acid
|
0 | C15H9N3O | |
GC36326-50mg |
|
951382-34-6 |
Ipragliflozin L-Proline
|
0 | C26H30FNO7S | |
GC36326-10mg |
|
951382-34-6 |
Ipragliflozin L-Proline
|
0 | C26H30FNO7S | |
GC36326-5mg |
|
951382-34-6 |
Ipragliflozin L-Proline
|
0 | C26H30FNO7S | |
GC36325-50mg |
|
212201-70-2 |
Ipfencarbazone
|
0 | C18H14Cl2F2N4O2 | |
GC36325-10mg |
|
212201-70-2 |
Ipfencarbazone
|
0 | C18H14Cl2F2N4O2 | |
GC36325-10mM (in 1mL DMSO) |
|
212201-70-2 |
Ipfencarbazone
|
0 | C18H14Cl2F2N4O2 | |
GC36324-500mg |
|
60166-93-0 |
Iopamidol
|
0 | C17H22I3N3O8 | |
GC36324-100mg |
|
60166-93-0 |
Iopamidol
|
0 | C17H22I3N3O8 | |
GC36324-10 mM ( 1 mL in Water) |
|
60166-93-0 |
Iopamidol
|
0 | C17H22I3N3O8 | |
GC36320-5mg |
|
181701-06-4 |
InteriotherinA
|
0 | C29H28O8 | |
GC36319-5mg |
|
1198786-98-9 |
INT-777 R-enantiomer
|
0 | C27H46O5 | |